| 1 |
Maiese K. Nicotinamide as a Foundation for Treating Neurodegenerative Disease and Metabolic Disorders. Curr Neurovasc Res 2021;18:134-49. [PMID: 33397266 DOI: 10.2174/1567202617999210104220334] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 2 |
Maiese K. Nicotinamide: Oversight of Metabolic Dysfunction Through SIRT1, mTOR, and Clock Genes. Curr Neurovasc Res 2020;17:765-83. [PMID: 33183203 DOI: 10.2174/1567202617999201111195232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 3 |
Chiu CC, Weng YH, Huang YZ, Chen RS, Liu YC, Yeh TH, Lu CS, Lin YW, Chen YJ, Hsu CC, Chiu CH, Wang YT, Chen WS, Liu SY, Wang HL. (D620N) VPS35 causes the impairment of Wnt/β-catenin signaling cascade and mitochondrial dysfunction in a PARK17 knockin mouse model. Cell Death Dis 2020;11:1018. [PMID: 33257649 DOI: 10.1038/s41419-020-03228-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 4 |
Fu X, Hong L, Yang Z, Tu Y, Xin W, Zha M, Tu S, Sun G, Li Y, Xiao W. MicroRNA-148a-3p suppresses epithelial-to-mesenchymal transition and stemness properties via Wnt1-mediated Wnt/β-catenin pathway in pancreatic cancer. J Cell Mol Med 2020;24:13020-35. [PMID: 33026174 DOI: 10.1111/jcmm.15900] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 5 |
Sferrazza G, Corti M, Brusotti G, Pierimarchi P, Temporini C, Serafino A, Calleri E. Nature-derived compounds modulating Wnt/ β -catenin pathway: a preventive and therapeutic opportunity in neoplastic diseases. Acta Pharm Sin B 2020;10:1814-34. [PMID: 33163337 DOI: 10.1016/j.apsb.2019.12.019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 6 |
Wallace J, Narasipura SD, Sha BE, French AL, Al-Harthi L. Canonical Wnts Mediate CD8+ T Cell Noncytolytic Anti-HIV-1 Activity and Correlate with HIV-1 Clinical Status. J Immunol 2020;205:2046-55. [PMID: 32887752 DOI: 10.4049/jimmunol.1801379] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Maiese K. Dysregulation of metabolic flexibility: The impact of mTOR on autophagy in neurodegenerative disease. Int Rev Neurobiol 2020;155:1-35. [PMID: 32854851 DOI: 10.1016/bs.irn.2020.01.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Marchetti B. Nrf2/Wnt resilience orchestrates rejuvenation of glia-neuron dialogue in Parkinson's disease. Redox Biol 2020;36:101664. [PMID: 32863224 DOI: 10.1016/j.redox.2020.101664] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 9 |
Rotherham M, Nahar T, Goodman T, Telling N, Gates M, El Haj A. Magnetic Mechanoactivation of Wnt Signaling Augments Dopaminergic Differentiation of Neuronal Cells. Adv Biosyst 2019;3:e1900091. [PMID: 32648650 DOI: 10.1002/adbi.201900091] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 10 |
Mehrabani M, Nematollahi MH, Tarzi ME, Juybari KB, Abolhassani M, Sharifi AM, Paseban H, Saravani M, Mirzamohammadi S. Protective effect of hydralazine on a cellular model of Parkinson’s disease: a possible role of hypoxia-inducible factor (HIF)-1α. Biochem Cell Biol 2020;98:405-14. [DOI: 10.1139/bcb-2019-0117] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 11 |
Maiese K. New Insights for nicotinamide: Metabolic disease, autophagy, and mTOR. Front Biosci (Landmark Ed) 2020;25:1925-73. [PMID: 32472766 DOI: 10.2741/4886] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 12 |
Loving BA, Bruce KD. Lipid and Lipoprotein Metabolism in Microglia. Front Physiol 2020;11:393. [PMID: 32411016 DOI: 10.3389/fphys.2020.00393] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 22.0] [Reference Citation Analysis]
|
| 13 |
Serafino A, Giovannini D, Rossi S, Cozzolino M. Targeting the Wnt/β-catenin pathway in neurodegenerative diseases: recent approaches and current challenges. Expert Opin Drug Discov 2020;15:803-22. [PMID: 32281421 DOI: 10.1080/17460441.2020.1746266] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 14 |
Hadi F, Akrami H, Shahpasand K, Fattahi MR. Wnt signalling pathway and tau phosphorylation: A comprehensive study on known connections. Cell Biochem Funct 2020;38:686-94. [PMID: 32232872 DOI: 10.1002/cbf.3530] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 15 |
González P, González-Fernández C, Campos-Martín Y, Mollejo M, Carballosa-Gautam M, Marcillo A, Norenberg M, Rodríguez FJ. Frizzled 1 and Wnt1 as new potential therapeutic targets in the traumatically injured spinal cord. Cell Mol Life Sci 2020;77:4631-62. [PMID: 31900623 DOI: 10.1007/s00018-019-03427-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 16 |
Gonzalez-Fernandez C, González P, Rodríguez FJ. New insights into Wnt signaling alterations in amyotrophic lateral sclerosis: a potential therapeutic target? Neural Regen Res 2020;15:1580-9. [PMID: 32209757 DOI: 10.4103/1673-5374.276320] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 17 |
Li Y, Liu Z, Wang D, Gao H, Zhu Z, Wang Y, Luo Q, Jiang S, Zhang J, Yang X. Ucf-101 protects in vivoandin vitro models of PD against 6-hydroxydopamine toxicity by alleviating endoplasmic reticulum stress via the Wnt/β-catenin pathway. J Clin Neurosci 2020;71:217-25. [PMID: 31883812 DOI: 10.1016/j.jocn.2019.11.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Wei L, Chen C, Ding L, Mo M, Zou J, Lu Z, Li H, Wu H, Dai Y, Xu P, Lu Z. Wnt1 Promotes EAAT2 Expression and Mediates the Protective Effects of Astrocytes on Dopaminergic Cells in Parkinson's Disease. Neural Plast 2019;2019:1247276. [PMID: 31582965 DOI: 10.1155/2019/1247276] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 19 |
Huang C, Ma J, Li BX, Sun Y. Wnt1 silencing enhances neurotoxicity induced by paraquat and maneb in SH-SY5Y cells. Exp Ther Med 2019;18:3643-9. [PMID: 31602242 DOI: 10.3892/etm.2019.7963] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 20 |
Maiese K. Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors. Curr Neurovasc Res 2018;15:81-91. [PMID: 29557749 DOI: 10.2174/1567202615666180319151244] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 21 |
Fang H, Li HF, Yang M, Wang RR, Wang QY, Zheng PC, Zhang FX, Zhang JP. microRNA-128 enhances neuroprotective effects of dexmedetomidine on neonatal mice with hypoxic-ischemic brain damage by targeting WNT1. Biomed Pharmacother. 2019;113:108671. [PMID: 30875657 DOI: 10.1016/j.biopha.2019.108671] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 22 |
Xicoy H, Wieringa B, Martens GJM. The Role of Lipids in Parkinson's Disease. Cells 2019;8:E27. [PMID: 30621069 DOI: 10.3390/cells8010027] [Cited by in Crossref: 105] [Cited by in F6Publishing: 110] [Article Influence: 26.3] [Reference Citation Analysis]
|
| 23 |
Albeely AM, Ryan SD, Perreault ML. Pathogenic Feed-Forward Mechanisms in Alzheimer's and Parkinson's Disease Converge on GSK-3. Brain Plast 2018;4:151-67. [PMID: 30598867 DOI: 10.3233/BPL-180078] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 24 |
Zhao F, Siedlak SL, Torres SL, Xu Q, Tang B, Zhu X. Conditional Haploinsufficiency of β-Catenin Aggravates Neuronal Damage in a Paraquat-Based Mouse Model of Parkinson Disease. Mol Neurobiol 2019;56:5157-66. [PMID: 30519817 DOI: 10.1007/s12035-018-1431-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 25 |
Marchetti B. Wnt/β-Catenin Signaling Pathway Governs a Full Program for Dopaminergic Neuron Survival, Neurorescue and Regeneration in the MPTP Mouse Model of Parkinson's Disease. Int J Mol Sci 2018;19:E3743. [PMID: 30477246 DOI: 10.3390/ijms19123743] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 10.2] [Reference Citation Analysis]
|
| 26 |
Maiese K. The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders. Biochem Soc Trans 2018;46:351-60. [PMID: 29523769 DOI: 10.1042/BST20170121] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 27 |
L'Episcopo F, Tirolo C, Serapide MF, Caniglia S, Testa N, Leggio L, Vivarelli S, Iraci N, Pluchino S, Marchetti B. Microglia Polarization, Gene-Environment Interactions and Wnt/β-Catenin Signaling: Emerging Roles of Glia-Neuron and Glia-Stem/Neuroprogenitor Crosstalk for Dopaminergic Neurorestoration in Aged Parkinsonian Brain. Front Aging Neurosci 2018;10:12. [PMID: 29483868 DOI: 10.3389/fnagi.2018.00012] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 28 |
Colini Baldeschi A, Pittaluga E, Andreola F, Rossi S, Cozzolino M, Nicotera G, Sferrazza G, Pierimarchi P, Serafino A. Atrial Natriuretic Peptide Acts as a Neuroprotective Agent in in Vitro Models of Parkinson's Disease via Up-regulation of the Wnt/β-Catenin Pathway. Front Aging Neurosci 2018;10:20. [PMID: 29449807 DOI: 10.3389/fnagi.2018.00020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 29 |
Maiese K. Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy. Curr Neurovasc Res 2016;13:329-40. [PMID: 27488211 DOI: 10.2174/1567202613666160729164900] [Cited by in Crossref: 17] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 30 |
Tiwari PC, Pal R. The potential role of neuroinflammation and transcription factors in Parkinson disease. Dialogues Clin Neurosci 2017;19:71-80. [PMID: 28566949 [PMID: 28566949 DOI: 10.31887/dcns.2017.19.1/rpal] [Cited by in Crossref: 88] [Cited by in F6Publishing: 88] [Article Influence: 14.7] [Reference Citation Analysis]
|
| 31 |
Choi PJ, Oh S, Liew H. Effect of SKL2001 on the neuronal survival mechanism in Parkinson’s disease. Mol Cell Toxicol 2017;13:165-70. [DOI: 10.1007/s13273-017-0017-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 32 |
Shen Z, Zhou Z, Gao S, Guo Y, Gao K, Wang H, Dang X. Melatonin Inhibits Neural Cell Apoptosis and Promotes Locomotor Recovery via Activation of the Wnt/β-Catenin Signaling Pathway After Spinal Cord Injury. Neurochem Res 2017;42:2336-43. [PMID: 28417262 DOI: 10.1007/s11064-017-2251-7] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 33 |
Serafino A, Sferrazza G, Colini Baldeschi A, Nicotera G, Andreola F, Pittaluga E, Pierimarchi P. Developing drugs that target the Wnt pathway: recent approaches in cancer and neurodegenerative diseases. Expert Opin Drug Discov 2017;12:169-86. [PMID: 27960558 DOI: 10.1080/17460441.2017.1271321] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 34 |
Pal R, Tiwari PC, Nath R, Pant KK. Role of neuroinflammation and latent transcription factors in pathogenesis of Parkinson’s disease. Neurological Research 2016;38:1111-22. [DOI: 10.1080/01616412.2016.1249997] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 35 |
Ahsani Z, Mohammadi-Yeganeh S, Kia V, Karimkhanloo H, Zarghami N, Paryan M. WNT1 Gene from WNT Signaling Pathway Is a Direct Target of miR-122 in Hepatocellular Carcinoma. Appl Biochem Biotechnol. 2017;181:884-897. [PMID: 27687586 DOI: 10.1007/s12010-016-2256-8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 36 |
Chen L, Mo M, Li G, Cen L, Wei L, Xiao Y, Chen X, Li S, Yang X, Qu S, Xu P. The biomarkers of immune dysregulation and inflammation response in Parkinson disease. Transl Neurodegener 2016;5:16. [PMID: 27570618 DOI: 10.1186/s40035-016-0063-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 37 |
Mathuram TL, Ravikumar V, Reece LM, Karthik S, Sasikumar CS, Cherian KM. Tideglusib induces apoptosis in human neuroblastoma IMR32 cells, provoking sub-G0/G1 accumulation and ROS generation. Environ Toxicol Pharmacol 2016;46:194-205. [PMID: 27490211 DOI: 10.1016/j.etap.2016.07.013] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 38 |
Libro R, Bramanti P, Mazzon E. The role of the Wnt canonical signaling in neurodegenerative diseases. Life Sci 2016;158:78-88. [PMID: 27370940 DOI: 10.1016/j.lfs.2016.06.024] [Cited by in Crossref: 93] [Cited by in F6Publishing: 99] [Article Influence: 13.3] [Reference Citation Analysis]
|
| 39 |
Maiese K. FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus. Curr Neurovasc Res 2015;12:404-13. [PMID: 26256004 DOI: 10.2174/1567202612666150807112524] [Cited by in Crossref: 35] [Cited by in F6Publishing: 50] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 40 |
Maiese K. Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR. Neural Regen Res 2016;11:372-85. [PMID: 27127460 DOI: 10.4103/1673-5374.179032] [Cited by in Crossref: 28] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 41 |
Zhang L, Cen L, Qu S, Wei L, Mo M, Feng J, Sun C, Xiao Y, Luo Q, Li S, Yang X, Xu P. Enhancing Beta-Catenin Activity via GSK3beta Inhibition Protects PC12 Cells against Rotenone Toxicity through Nurr1 Induction. PLoS One 2016;11:e0152931. [PMID: 27045591 DOI: 10.1371/journal.pone.0152931] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 42 |
Dong J, Li S, Mo JL, Cai HB, Le WD. Nurr1-Based Therapies for Parkinson's Disease. CNS Neurosci Ther 2016;22:351-9. [PMID: 27012974 DOI: 10.1111/cns.12536] [Cited by in Crossref: 77] [Cited by in F6Publishing: 80] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 43 |
Maiese K. Novel Stem Cell Strategies with mTOR. Molecules to Medicine with mTOR 2016. [DOI: 10.1016/b978-0-12-802733-2.00020-7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 44 |
Maiese K. Programming apoptosis and autophagy with novel approaches for diabetes mellitus. Curr Neurovasc Res 2015;12:173-88. [PMID: 25742566 DOI: 10.2174/1567202612666150305110929] [Cited by in Crossref: 21] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 45 |
Maiese K. Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders. Br J Clin Pharmacol 2016;82:1245-66. [PMID: 26469771 DOI: 10.1111/bcp.12804] [Cited by in Crossref: 95] [Cited by in F6Publishing: 116] [Article Influence: 11.9] [Reference Citation Analysis]
|
| 46 |
Maiese K. Erythropoietin and diabetes mellitus. World J Diabetes 2015; 6(14): 1259-1273 [PMID: 26516410 DOI: 10.4239/wjd.v6.i14.1259] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 47 |
Maiese K. Novel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic disease. Neural Regen Res. 2015;10:518-528. [PMID: 26170801 DOI: 10.4103/1673-5374.155427] [Cited by in Crossref: 38] [Cited by in F6Publishing: 55] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 48 |
Cui Z, Zhou L, Song Y, Liu C, Zhu G, Wu X, Yan Y, Xia X, Duan C, Zhou Y, Huang Y, Zhang D. Up-Regulation of Corticocerebral NKD2 in Lipopolysaccharide-Induced Neuroinflammation. Cell Mol Neurobiol 2016;36:47-55. [DOI: 10.1007/s10571-015-0219-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 49 |
Wei L, Ding L, Mo MS, Lei M, Zhang L, Chen K, Xu P. Wnt3a protects SH-SY5Y cells against 6-hydroxydopamine toxicity by restoration of mitochondria function. Transl Neurodegener 2015;4:11. [PMID: 26085927 DOI: 10.1186/s40035-015-0033-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 50 |
Maiese K. FoxO proteins in the nervous system. Anal Cell Pathol (Amst). 2015;2015:569392. [PMID: 26171319 DOI: 10.1155/2015/569392] [Cited by in Crossref: 24] [Cited by in F6Publishing: 53] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 51 |
Maiese K. New Insights for Oxidative Stress and Diabetes Mellitus. Oxid Med Cell Longev. 2015;2015:875961. [PMID: 26064426 DOI: 10.1155/2015/875961] [Cited by in Crossref: 122] [Cited by in F6Publishing: 143] [Article Influence: 15.3] [Reference Citation Analysis]
|
| 52 |
Wang C, Qin L, Min Z, Zhao Y, Zhu L, Zhu J, Yu S. SOX7 interferes with β-catenin activity to promote neuronal apoptosis. Eur J Neurosci 2015;41:1430-7. [PMID: 25847511 DOI: 10.1111/ejn.12910] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 53 |
Segura-Aguilar J, Kostrzewa RM. Neurotoxin mechanisms and processes relevant to Parkinson's disease: an update. Neurotox Res 2015;27:328-54. [PMID: 25631236 DOI: 10.1007/s12640-015-9519-y] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 54 |
Jeong JK, Lee JH, Moon JH, Lee YJ, Park SY. Melatonin-mediated β-catenin activation protects neuron cells against prion protein-induced neurotoxicity. J Pineal Res 2014;57:427-34. [PMID: 25251028 DOI: 10.1111/jpi.12182] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 55 |
Yew MY, Koh RY, Chye SM, Othman I, Ng KY. Edible bird's nest ameliorates oxidative stress-induced apoptosis in SH-SY5Y human neuroblastoma cells. BMC Complement Altern Med 2014;14:391. [PMID: 25308934 DOI: 10.1186/1472-6882-14-391] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 56 |
Jiang J, Shi S, Zhou Q, Ma X, Nie X, Yang L, Han J, Xu G, Wan C. Downregulation of the Wnt/β-catenin signaling pathway is involved in manganese-induced neurotoxicity in rat striatum and PC12 cells. J Neurosci Res 2014;92:783-94. [PMID: 24464479 DOI: 10.1002/jnr.23352] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 57 |
L'Episcopo F, Tirolo C, Caniglia S, Testa N, Morale MC, Serapide MF, Pluchino S, Marchetti B. Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease. J Mol Cell Biol 2014;6:13-26. [PMID: 24431301 DOI: 10.1093/jmcb/mjt053] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 58 |
Parish CL, Thompson LH. Modulating Wnt signaling to improve cell replacement therapy for Parkinson's disease. Journal of Molecular Cell Biology 2014;6:54-63. [DOI: 10.1093/jmcb/mjt045] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 59 |
Verma M, Steer EK, Chu CT. ERKed by LRRK2: a cell biological perspective on hereditary and sporadic Parkinson's disease. Biochim Biophys Acta 2014;1842:1273-81. [PMID: 24225420 DOI: 10.1016/j.bbadis.2013.11.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
|
